You just read:

Epic Sciences Announces Completion of New York State Licensure to Provide the Oncotype DX AR-V7 Nucleus Detect Test for Patients with Metastatic Castration-Resistant Prostate Cancer in New York State

News provided by

Epic Sciences, Inc.

Mar 20, 2019, 08:00 ET